Vancomycin prophylaxis of surgical site infection in clean orthopedic surgery

Orthopedics

Volumn 36, Issue 2, 2013, Pages 138-146

  Kanj, Wajdi W ^a   Flynn, John M ^a   Spiegel, David A ^a   Dormans, John P ^a   Baldwin, Keith D ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; HYDROXYAPATITE; VANCOMYCIN;

ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; CLEAN ORTHOPEDIC SURGERY; DISEASE PREDISPOSITION; DRUG BONE LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; INFECTION RATE; INFUSION RATE; LIVER TOXICITY; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEPHROTOXICITY; ORTHOPEDIC SURGERY; OTOTOXICITY; POSTOPERATIVE INFECTION; PROTEINURIA; PRURITUS; RED MAN SYNDROME; REVIEW; SPINE SURGERY; SURGICAL INFECTION; SYSTEMATIC REVIEW; THROMBOPHLEBITIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; ORTHOPEDIC PROCEDURES; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 84874059176     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20130122-10     Document Type: Review

References (35)

1. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet. 1981; 1(8224):795-796.
2. Doyon F, Evrard J, Mazas F, Hill C. Long-term results of prophylactic cefazolin versus placebo in total hip replacement. Lancet. 1987; 1(8537):860.
3. Boyd RJ, Burke JF, Colton T. A double-blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg Am. 1973; 55(6):1251-1258.
4. Chen LF, Chastain C, Anderson DJ. Community-acquired methicillin- resistant Staphylococcus aureus skin and soft tissue infections: management and prevention. Curr Infect Dis Rep. 2011; 13(5):442-450.
5. Rahman RK, Lenke LG, Bridwell KH, et al. Intrawound vancomycin powder lowers the acute deep wound infection rate in adult spinal deformity patients. Paper presented at: Scoliosis Research Society 46th Annual Meeting & Course; September 14-17, 2011; Louisville, K Y.
6. Gupta K, Strymish J, Abi-Haidar Y, Williams SA, Itani KM. Preoperative nasal methicillin-resistant Staphylococcus aureus status, surgical prophylaxis, and risk-adjusted postoperative outcomes in veterans. Infect Control Hosp Epidemiol. 2011; 32(8):791-796.
7. Sorrell TC, Collignon PJ. A prospective study of adverse reactions associated with van-comycin therapy. J Antimicrob Chemother. 1985; 16(2):235-241.
8. Mellor JA, Kingdom J, Cafferkey M, Keane CT. Vancomycin toxicity: a prospective study. J Antimicrob Chemother. 1985; 15(6):773-780.
9. Savarese A, Nanni ML, Pasquali C, Egidio AC. Vancomycin prophylaxis in joint arthroplasty. Chir Organi Mov. 1999; 84(3):247-251.
10. Wazny LD, Daghigh B. Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother. 2001; 35(11):1458-1464.
11. Kupstaite R, Baranauskaite A, Pileckyte M, Sveikata A, Kadusevicius E, Muckiene G. Severe vancomycin-induced anaphylactic reaction. Medicina (Kaunas). 2010; 46(1):30-33.
12. Brien WW, Salvati EA, Klein R, Brause B, Stern S. Antibiotic impregnated bone cement in total hip arthroplasty. An in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop Relat Res. 1993; (296):242-248.
13. Eshkenazi AU, Garti A, Tamir L, Hendel D. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty. Am J Knee Surg. 2001; 14(4):221-223.
14. Zaza S, Wright-De Aguero LK, Briss PA, et al. Data collection instrument and procedure for systematic reviews in the guide to community preventive services. Am J Prev Med. 2000; 18(1):44-74.
15. Assor M. Noncemented total knee arthroplasty with a local prophylactic anti-infection agent: a prospective series of 135 cases. Can J Surg. 2010; 53(1):47-50.
16. Buttaro MA, Guala AJ, Comba F, Suarez F, Piccaluga F. Incidence of deep infection in aseptic revision tha using vancomycin-impregnated impacted bone allograft. Hip Int. 2010; 20(4):535-541.
17. Chiu FY, Lin CF. Antibiotic-impregnated cement in revision total knee arthroplasty. A prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg Am. 2009; 91(3):628-633.
18. Klekamp J, Spengler DM, McNamara MJ, Haas DW. Risk factors associated with methicillin-resistant staphylococcal wound infection after spinal surgery. J Spinal Disord. 1999; 12(3):187-191.
19. O'Neill KR, Smith JG, Abtahi AM, et al. Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J. 2011; 11(7):641-646.
20. Ritter MA, Barzilauskas CD, Faris PM, Keating EM. Vancomycin prophylaxis and elective total joint arthroplasty. Orthopedics. 1989; 12(10):1333-1336.
21. Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011; 36(24):2084-2088.
22. Tyllianakis ME, Karageorgos A, Marangos MN, Saridis AG, Lambiris EE. Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents. J Arthroplasty. 2010; 25(7):1078-1082.
23. Smith EB, Wynne R, Liu H, Good RP. Time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint replacement patients? American Association of Hip and Knee Surgeons 23rd Annual Meeting; November 8-10, 2011; Dallas, TX.
24. Molinari WJ, Khera O, Molinari RW. Prophylactic operative site powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases during a six-year period. Paper presented at: Scoliosis Research Society 46th Annual Meeting & Course; September 14-17, 2011; Louisville, KY.
25. Pahys J, Pahys JR, Cho SK, et al. Methods to decrease post-operative infections following posterior cervical spine surgery. American Academy of Orthopaedic Surgeons 2011 Annual Meeting; February 15-19, 2011; San Diego, CA.
26. Evans RP. Surgical site infection prevention and control: an emerging paradigm. J Bone Joint Surg Am. 2009; 91 suppl 6:2-9.
27. Calderone RR, Garland DE, Capen DA, Oster H. Cost of medical care for postoperative spinal infections. Orthop Clin North Am. 1996; 27(1):171-182.
28. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29(11):996-1011.
29. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46 suppl 5:S344-S349.
30. Morange-Saussier V, Giraudeau B, van der Mee N, Lermusiaux P, Quentin R. Nasal carriage of methicillin-resistant Staphylococcus aureus in vascular surgery. Ann Vasc Surg. 2006; 20(6):767-772.
31. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010; 92(9):1820-1826.
32. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther. 2001; 43(1116-1117):92-97.
33. Baiocchi P, Capone A, Carfagna P, Santini C, Venditti M. Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among Staphylococcus aureus isolates in a tertiary-care university hospital. Int J Antimicrob Agents. 1996; 7(2):93-96.
34. Johnson AP, Uttley AH, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990; 3(3):280-291.
35. Borkhuu B, Borowski A, Shah SA, Littleton AG, Dabney KW, Miller F. Antibiotic-loaded allograft decreases the rate of acute deep wound infection after spinal fusion in cerebral palsy. Spine (Phila Pa 1976). 2008; 33(21):2300-2304.